SHARx, LLC.

Call Directions Website

SHARx, LLC. SHARx (pronounced “sharks”) was designed to serve the uninsured and underinsured populations that are struggling to afford lifesaving medications.

SHARx removes barriers and helps ensure affordable access to high-cost maintenance & specialty medications. https://linktr.ee/sharxllc

Subcutaneous = self-injectable, right? Not necessarily.One of the challenges with injectable medications is that the rou...
11/03/2026

Subcutaneous = self-injectable, right? Not necessarily.

One of the challenges with injectable medications is that the route of administration doesn’t tell the whole story.

Some SubQ (subcutaneous/below the skin) medications are designed for patients to administer themselves. Others must be administered by a healthcare professional. IM (intramuscular/into the muscle) medications can similarly vary between home and healthcare settings. IV (intravenous/into the vein) medications require professional administration, but even then, the appropriate setting can vary. Some therapies may also use different routes during different stages of treatment.

And these differences go beyond where someone receives a medication.

How the medication is obtained and administered can also affect how it appears in claims. Medications dispensed directly to a member commonly appear under the pharmacy benefit using an NDC, while provider-purchased and administered medications may appear under the medical benefit using a J- or Q-code.

The route is one piece of the puzzle. The complete medication pathway is what matters.

Understanding who administers a medication, where it can be administered, and how it is obtained provides a much clearer picture.

Happy Halloween from SHARx!
10/31/2026

Happy Halloween from SHARx!

Spooktacular times at yesterday’s Trunk or Treat! Hosted by our Member Operations Employee Engagement Committee, our tea...
10/30/2026

Spooktacular times at yesterday’s Trunk or Treat! Hosted by our Member Operations Employee Engagement Committee, our team truly showed up and showed out with incredible costumes, delicious candy & snacks, freshly grilled hot dogs and brats, and homemade c***r crafted by one of our own. We had a blast enjoying great company and casting votes for best costume and best decorated trunk.

A huge thank you to everyone who showed up, decorated, and brought the festive energy to make this event such a success. We love celebrating with this amazing team! 🎃🦇👻

10/30/2026

'𝐎𝐧 𝐭𝐡𝐞 𝐑𝐚𝐝𝐚𝐫' | 33rd Edition is live!

Rising healthcare costs are putting employers under pressure, while shifts in drug pricing, pharmacy benefits, and industry competition are changing the rules of the game.

This edition discusses:
- Why employer healthcare costs could rise nearly 9% in 2027
- New drug launch prices increasing 35%
- Growing PBM market concentration and continued regulatory scrutiny
- Pharmaceutical manufacturers expanding direct-to-consumer models
- How patent expirations are reshaping the pharmaceutical industry

Employers need to look beyond utilization and traditional cost-management strategies to better understand the pricing structures, market dynamics, and vendor relationships driving healthcare spend.

Check out the thirty-third edition: 🔗 https://sharxplan.com/on-the-radar-33rd-edition/

Health benefit costs are projected to rise 8.2% in 2027, the biggest jump since 2003. For many employers, the first inst...
10/28/2026

Health benefit costs are projected to rise 8.2% in 2027, the biggest jump since 2003. For many employers, the first instinct is to cut coverage or shift costs to employees.

SHARx Co-founder and CGO Paul Pruitt says start somewhere else: “Before asking employees to absorb more of the cost, employers should understand what they are paying for, where the pharmacy dollars are going, and whether they have exhausted opportunities to reduce the underlying cost of the benefit.”

That means knowing how your PBM gets paid, what your claims data shows, and whether better access options exist for your most expensive drugs.

Full article: 🔗 https://sharxplan.com/news/employers-are-overlooking-a-better-way-to-control-healthcare-costs/

🌶️🔥 The 5th Annual Chili Cook-off, hosted by the SHARx Culture Club, was an absolute hit!Our team showed off their amazi...
10/22/2026

🌶️🔥 The 5th Annual Chili Cook-off, hosted by the SHARx Culture Club, was an absolute hit!

Our team showed off their amazing culinary skills with 10 delicious chili varieties. Thank you to everyone who made this event possible, whether you brought a crockpot, cast a vote, or just came to enjoy the feast. A special congratulations goes out to our chili champions who took home top honors this year.

We love celebrating our vibrant workplace culture through fun, flavor-filled traditions like this!

10/16/2026

'𝐎𝐧 𝐭𝐡𝐞 𝐑𝐚𝐝𝐚𝐫' | 32nd Edition is live!

PBM reform is gaining momentum, but will greater transparency actually lead to lower pharmacy costs?

In this edition, we cover
• Why bigger PBM rebates aren't translating into lower employer drug spend
• The Big Three PBMs losing ground as employers explore alternatives
• New challenges threatening access to affordable prescription imports
• Drug launch prices reaching new highs
• Growing pressure on employers from hospital and pharmaceutical pricing
• The ongoing debate over prior authorization and medication access

Transparency is only part of the solution. Employers need to look beyond rebates and pricing models to understand total pharmacy spend, clinical value, and the true financial impact on their plans.

Check out the thirty-second edition: 🔗 https://sharxplan.com/on-the-radar-32nd-edition/

Employers are increasingly stepping up as healthcare purchasers, and trusting the old plan model is no longer enough. To...
10/02/2026

Employers are increasingly stepping up as healthcare purchasers, and trusting the old plan model is no longer enough. To control rising costs and hidden fees, leaders must demand full visibility into their spending.

As Paul Pruitt, co-founder and CGO at SHARx, notes: “Transparency should no longer be viewed as a luxury; it should be an expectation. Employers cannot effectively manage any major business expense if they cannot see the underlying data.”

Read the full article to learn how to evaluate your organization's healthcare strategy and uncover hidden costs: 🔗 https://sharxplan.com/news/whos-really-managing-your-healthcare-dollars/

10/02/2026

'𝐎𝐧 𝐭𝐡𝐞 𝐑𝐚𝐝𝐚𝐫' | 31st Edition is live!

Healthcare costs are rising, but the bigger challenge is understanding what’s actually driving them.

This edition covers:
• Why unclear prescription prices are affecting patient behavior
• New tools for evaluating PBM contracts and fiduciary protections
• Why employers are moving beyond traditional cost-shifting
• Pharmacy benefits becoming a bigger C-suite priority
• The expanding role of brokers in healthcare cost management

Managing pharmacy spend requires looking beyond the price tag to contracts, competition, utilization, patient access, and fiduciary oversight.

Check out the thirty-first edition: 🔗 https://sharxplan.com/on-the-radar-31st-edition/

While national policy discussions focus on Most-Favored-Nation drug pricing deals, simply lowering manufacturer costs do...
09/23/2026

While national policy discussions focus on Most-Favored-Nation drug pricing deals, simply lowering manufacturer costs does not automatically translate to relief at the pharmacy counter.

"All of Pharma seems to have these long-term contractual agreements with the government programs and the commercial markets, and they're all intertwined and interconnected in a very challenging way that is not easy to unwind," explained SHARx Chief Growth Officer Paul Pruitt.

Read the article to explore the hidden tradeoffs and complexities behind these sweeping pricing agreements: 🔗 https://sharxplan.com/news/a-hidden-tradeoff-in-trumps-mfn-drug-deals/

Address

635 Maryville Center Drive
St. Louis, MO
63141

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Telephone

+13144513555

Alerts

Be the first to know and let us send you an email when SHARx, LLC. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share


Other Pharmaceutical Companies in St. Louis

Show All